Brief: Alivus Life Sciences Q3 Profit 1.5 Billion Rupees
22/01/2026 08:21
Jan 22 (Reuters) - Alivus Life Sciences Ltd ALIV.NS: Q3 PROFIT 1.5 BILLION RUPEES Q3 REVENUE FROM OPERATIONS 6.73 BILLION RUPEES Source text: ID:nnAZN4S2NHI Further company coverage: ALIV.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alivus Life Sciences
See all newsBrief: Alivus Life Sciences Incorporates Subsidiary Alivus Life Sciences Do Brasil Ltda In Brazil
Brief: Alivus Life Sciences To Buy 76% Stake In Iqgen-X Pharma For Approx 91.2 Million Rupees
India's Alivus rises to 15-month high as brokerages optimistic about drugmaker's annual outlook
India's Alivus Life Sciences rises after quarterly profit increase
Brief: Alivus Life Sciences Ltd March-Quarter Profit 1.63 Billion Rupees